
Sign up to save your podcasts
Or


In the second portion of our two part-series on AML maintenance, Anthony and Bernie delve into the studies of post-transplant FLT3 inhibitor maintenance. We discuss the controversial MORPHO study of gilteritinib and whether these results will change practice!
By Bernard Marini, Anthony Perissinotti, et al.4.5
3030 ratings
In the second portion of our two part-series on AML maintenance, Anthony and Bernie delve into the studies of post-transplant FLT3 inhibitor maintenance. We discuss the controversial MORPHO study of gilteritinib and whether these results will change practice!

38,430 Listeners

26,012 Listeners

87,868 Listeners

113,121 Listeners

56,944 Listeners

187 Listeners

10,331 Listeners

7,244 Listeners

53 Listeners

8 Listeners

16,525 Listeners

11,013 Listeners

51 Listeners

195 Listeners

747 Listeners